News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
183 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (8)
2 (146)
3 (83)
4 (7)
5 (215)
6 (50)
7 (4)
8 (8)
9 (162)
10 (176)
11 (140)
12 (138)
13 (79)
14 (3)
15 (2)
16 (148)
17 (198)
18 (151)
19 (189)
20 (83)
21 (5)
22 (6)
23 (133)
24 (183)
25 (184)
26 (185)
27 (83)
28 (1)
29 (3)
30 (152)
31 (162)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Policy
Librede Inc. Receives Patent for Cannabidiolic Acid (CBDA) Production in Yeast
Librede has been granted a new patent for the production of cannabidiolic acid (CBDA) in microorganisms.
July 24, 2018
·
2 min read
Drug Development
ViiV Healthcare announces SWORD 100-week data for Juluca (dolutegravir/rilpivirine) at AIDS 2018
Juluca, the first 2-drug regimen, once daily, single pill regimen, maintains viral suppression through 100 weeks
July 24, 2018
·
13 min read
Business
BioAtla Appoints Lawrence Fong, M.D. As Scientific Advisor
Leading clinical researcher in cancer immunotherapy will advise BioAtla on clinical trial designs of the company’s proprietary CABs in combination therapies
July 24, 2018
·
3 min read
Nucleix Announces Publication of Non-Invasive Bladder Cancer Recurrence Detection Study Showing Best-in-Class Performance
Results of the European multi-center study of Bladder EpiCheck™ urine test, supporting reduction of invasive procedures, were published in the European Urology Oncology journal
July 24, 2018
·
4 min read
Business
Delphi Behavioral Health Group Announces Opening of New Perspectives
Leading Health Group Adds New South Florida Outpatient Treatment Facility
July 24, 2018
·
3 min read
Business
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
Soligenix intends to leverage Mr. Pearson’s extensive business and investing experience
July 24, 2018
·
6 min read
BioMidwest
Lilly to Separate Elanco Animal Health with Initial Public Offering
Company has completed its strategic review of Elanco Animal Health, and will file a registration statement in the coming weeks with the U.S. Securities and Exchange Commission
July 24, 2018
·
3 min read
Business
Avery Dennison Announces Second Quarter 2018 Results
2Q18 Reported EPS of $1.07
July 24, 2018
·
30 min read
Biotech Bay
Bay Materials Releases Zendura™ AT, an Advanced Material Aiding Orthodontic Clear Aligner Therapy
Bay Materials LLC announced that it has released Zendura™ AT, the first and only material engineered especially for fabricating aligner attachment templates.
July 24, 2018
·
2 min read
Business
Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer
Bristol-Myers Squibb Company and Tsinghua University, have entered into a collaboration to discover therapeutic agents against novel targets for autoimmune diseases and cancers.
July 24, 2018
·
3 min read
Previous
7 of 19
Next